http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104606148-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
filingDate | 2014-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104606148-B |
titleOfInvention | A kind of Andrographolide in Andrographolide for Injection preparation and preparation method thereof |
abstract | The present invention relates to Andrographolide in Andrographolide for Injection lyophilized formulations and preparation method thereof.The lyophilized formulations are that andrographolide and a certain proportion of auxiliary material are dissolved in water for injection, and by aseptic filtration, freeze-drying is made, and the auxiliary material includes glycerine and mannitol, andrographolide:Glycerine:The weight ratio of mannitol is 20:1~2.5:0.4~0.62.Andrographolide in Andrographolide for Injection lyophilized formulations stability produced by the present invention is good, and solution is clarified after redissolution, significantly improves product quality, it is ensured that the security and validity of product. |
priorityDate | 2014-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.